Report cover image

Injectable Drug Delivery Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Publisher Fortune Business Insights Pvt. Ltd.
Published Dec 01, 2024
Length 135 Pages
SKU # FOB19410887

Description

Injectable Drug Delivery Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Injectable Drug Delivery Market

The Injectable Drug Delivery market size was valued at USD 483.5 billion in 2019, and the market is now projected to grow to USD 2,651.3 billion in 2028 exhibiting a CAGR of 13.1% during the forecast period of 2024.

During the COVID -19 pandemic vaccines and therapeutic injectables have been on high demand, and this affected the injectable drug delivery system. The COVID-19 vaccine development and delivery showed the potential of injectable formulations and systems in the intensified drug delivery management. The growth and advancements in prefilled syringes, auto-injectors, and vial systems were brought forward to address emergent requirements. Nonetheless, it encountered issues in supply chain disruptions and manufacturing at the beginning of its production process. The pandemic also created better understanding of Home-Use Drug Delivery Systems on global level and Increased usage of portable, easy to use devices.

The injectable drug delivery system is promising due to the advances in the biologics market, rising incidence rates of diseases, and a focus on controlled drug delivery systems. The improvement in formulation and delivery system that include; pre-filled syringe and auto- injection has a positive effect on patient’s compliance and averagely satisfy all patients. The increasing number of elderly people and the increase in home healthcare also help to drive the market. Moreover, technologies, such as biosimilars and self-administration devices contribute to growth. This drive is supported by relevant regulatory policies, measures, technological innovations and increased awareness of many injectable treatments targeting diseases such as diabetes, cancer, and autoimmune illnesses among others. Thus, all the above mentioned factors are contributing towards injectable drug delivery market growth.

Some of the trends seen in the injectable drug delivery market include an increasing customer usage of self-injecting systems like autoinjectors and wearable injectors that improve the customer’s experience. Prefilled syringes are becoming popular because they are very accurate and are more secured from contamination. Biologic products, biosimilars and other advanced classes of drugs push needs for enhanced delivery methods. Following the recent advances in digital health technologies, smart injectors are gradually appearing to control the dosage level and patient’s adherence. Reuse of materials and organic or recyclable parts guarantee sustainability issues are handled in device production. Also, the trend in home and self-administered care increases the need for comfortable injectable solutions.

Comprehensive Analysis Injectable Drug Delivery Market

Geographically, the injectable drug delivery market is divided by device type, product type and end users. In terms of the device type, it comprises electronic injectables, prefilled syringes, auto- injectors, pen- injectors and wearable injectors to meet the various therapeutic utility. By product type the market is separate freeze-dried products and injectable sterile products to meet the stability and sterilities. By end-user, it extends to hospitals, homes care, clinics or others, which draws segment from different healthcare outlets. This segmentation helps in developing innovations and services to address customer needs for improvement and convenience in drug delivery systems.

North America is the largest market for injectable drug delivery due to its well established health care sector, the increasing focus on the use of advanced technologies and high investment in research and development. The area has large players in the industry and increasing trend to take more biologics and biosimilars into the market. Other trends including steadily growing incidence rates for chronic illnesses, greater understanding of the uses for self-injection instruments, and favorable rulings also contribute to industry expansion. Moreover, the technological shift towards home healthcare and the increasing portfolio of injectable therapies make North America the largest market for DMCs.

Key players in this sector include BD (New Jersey, U.S), SHL Medical AG (Switzerland, Europe), Schott AG (Germany, Europe), West Pharmaceutical Services, Inc. (Pennsylvania, U.S), Pfizer Inc. (New York, U.S), Insulet Corporation (Massachusetts, U.S), Elcam Medical (Israel, Middle East), Eli Lilly and Company (Indiana, U.S), Ypsomed AG (Switzerland, Europe), Gerresheimer AG (Germany, Europe), Baxter International Inc (Illinois, U.S).

Another important injectable drug delivery system trend observed in 2024 is the sustainability of injectable drug delivery systems such as the Eco-inject® auto injector a bio-based polymeric system. This new approach is parallel to the growing awareness of the environmentally sensitive devices in medical applications and still retains the basic function of a conventional auto-injector. Moreover, fine needle applications are also attracting increasing attention for the use in delivering drugs in therapy like gene therapy and/or for cancer treatment to deliver drugs for particular tissues/ organs. These developments point to the environmental and patient-centered innovations that have defined the sector.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2016-2027

Base Year 2019

Forecast Period 2020-2027

Historical Period 2016-2018

Unit Value (USD Billion)

By Device TypeConventional Injectable

Pre-filled Syringes

Auto-injectors

Pen-injectors

Wearable

By Product TypeFreeze-dried Products

Injectable Sterile Products

By End UserHospitals

Home Care Settings

Clinics

Others

By GeographyNorth America (the USA, and Canada)

Europe (UK, Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

Latin America (Brazil, Mexico and the Rest of the Latin America)

Middle East & Africa (South Africa, GCC and the Rest of the Middle East & Africa)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

135 Pages
1. Introduction
1.1. Market Scope
1.2. Market Segmentation
1.3. Market Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Key Diseases - For Key Countries, 2019
4.2. New Product Launch
4.3. Overview of Technological Advancements In Injectable Drug Delivery Devices
4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships
5. Global Injectable Drug Delivery Market Analysis, Insights and Forecast, 2016-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Device Type
5.2.1. Conventional Injectables
5.2.2. Pre-filled Syringes
5.2.3. Auto-injectors
5.2.4. Pen-injectors
5.2.5. Wearable
5.3. Market Analysis, Insights and Forecast – By Product Type
5.3.1. Freeze-dried Products
5.3.2. Injectable Sterile Products
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1. Hospitals
5.4.2. Homecare Settings
5.4.3. Clinics
5.4.4. Others
5.5. Market Analysis, Insights and Forecast – By Geography
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Injectable Drug Delivery Market Analysis, Insights and Forecast, 2016-2027
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Device Type
6.2.1. Conventional Injectables
6.2.2. Pre-filled Syringes
6.2.3. Auto-injectors
6.2.4. Pen-injectors
6.2.5. Wearable
6.3. Market Analysis, Insights and Forecast – By Product Type
6.3.1. Freeze-dried Products
6.3.2. Injectable Sterile Products
6.4. Market Analysis, Insights and Forecast – By End User
6.4.1. Hospitals
6.4.2. Homecare Settings
6.4.3. Clinics
6.4.4. Others
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Injectable Drug Delivery Market Analysis, Insights and Forecast, 2016-2027
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Device Type
7.2.1. Conventional Injectables
7.2.2. Pre-filled Syringes
7.2.3. Auto-injectors
7.2.4. Pen-injectors
7.2.5. Wearable
7.3. Market Analysis, Insights and Forecast – By Product Type
7.3.1. Freeze-dried Products
7.3.2. Injectable Sterile Products
7.4. Market Analysis, Insights and Forecast – By End User
7.4.1. Hospitals
7.4.2. Homecare Settings
7.4.3. Clinics
7.4.4. Others
7.5. Market Analysis, Insights and Forecast – By Country/Sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Injectable Drug Delivery Market Analysis, Insights and Forecast, 2016-2027
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Device Type
8.2.1. Conventional Injectables
8.2.2. Pre-filled Syringes
8.2.3. Auto-injectors
8.2.4. Pen-injectors
8.2.5. Wearable
8.3. Market Analysis, Insights and Forecast – By Product Type
8.3.1. Freeze-dried Products
8.3.2. Injectable Sterile Products
8.4. Market Analysis, Insights and Forecast – By End User
8.4.1. Hospitals
8.4.2. Homecare Settings
8.4.3. Clinics
8.4.4. Others
8.5. Market Analysis, Insights and Forecast – By Country/Sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Injectable Drug Delivery Market Analysis, Insights and Forecast, 2016-2027
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Device Type
9.2.1. Conventional Injectables
9.2.2. Pre-filled Syringes
9.2.3. Auto-injectors
9.2.4. Pen-injectors
9.2.5. Wearable
9.3. Market Analysis, Insights and Forecast – By Product Type
9.3.1. Freeze-dried Products
9.3.2. Injectable Sterile Products
9.4. Market Analysis, Insights and Forecast – By End User
9.4.1. Hospitals
9.4.2. Homecare Settings
9.4.3. Clinics
9.4.4. Others
9.5. Market Analysis, Insights and Forecast – By Country/Sub-region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa Injectable Drug Delivery Market Analysis, Insights and Forecast, 2016-2027
10.1. Key Findings / Summary
10.2. Market Analysis, Insights and Forecast – By Device Type
10.2.1. Conventional Injectables
10.2.2. Pre-filled Syringes
10.2.3. Auto-injectors
10.2.4. Pen-injectors
10.2.5. Wearable
10.3. Market Analysis, Insights and Forecast – By Product Type
10.3.1. Freeze-dried Products
10.3.2. Injectable Sterile Products
10.4. Market Analysis, Insights and Forecast – By End User
10.4.1. Hospitals
10.4.2. Homecare Settings
10.4.3. Clinics
10.4.4. Others
10.5. Market Analysis, Insights and Forecast – By Country/Sub-region
10.5.1. GCC
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2019)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Product Type Types & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
11.5.1. BD
11.5.1.1. Overview,
11.5.1.2. Product Type& Services,
11.5.1.3. SWOT Analysis,
11.5.1.4. Recent Developments,
11.5.1.5. Strategies,
11.5.1.6. Financials (Based on Availability)
11.5.2. SHL Group
11.5.2.1. Overview,
11.5.2.2. Product Type& Services,
11.5.2.3. SWOT Analysis,
11.5.2.4. Recent Developments,
11.5.2.5. Strategies,
11.5.2.6. Financials (Based on Availability)
11.5.3. Schott AG
11.5.3.1. Overview,
11.5.3.2. Product Type& Services,
11.5.3.3. SWOT Analysis,
11.5.3.4. Recent Developments,
11.5.3.5. Strategies,
11.5.3.6. Financials (Based on Availability)
11.5.4. West Pharmaceutical Services, Inc.
11.5.4.1. Overview,
11.5.4.2. Product Type& Services,
11.5.4.3. SWOT Analysis,
11.5.4.4. Recent Developments,
11.5.4.5. Strategies,
11.5.4.6. Financials (Based on Availability)
11.5.5. Pfizer Inc.
11.5.5.1. Overview,
11.5.5.2. Product Type& Services,
11.5.5.3. SWOT Analysis,
11.5.5.4. Recent Developments,
11.5.5.5. Strategies,
11.5.5.6. Financials (Based on Availability)
11.5.6. Insulet Corporation
11.5.6.1. Overview,
11.5.6.2. Product Type& Services,
11.5.6.3. SWOT Analysis,
11.5.6.4. Recent Developments,
11.5.6.5. Strategies,
11.5.6.6. Financials (Based on Availability)
11.5.7. Elcam Medical
11.5.7.1. Overview,
11.5.7.2. Product Type& Services,
11.5.7.3. SWOT Analysis,
11.5.7.4. Recent Developments,
11.5.7.5. Strategies,
11.5.7.6. Financials (Based on Availability)
11.5.8. Eli Lilly and Company
11.5.8.1. Overview,
11.5.8.2. Product Type& Services,
11.5.8.3. SWOT Analysis,
11.5.8.4. Recent Developments,
11.5.8.5. Strategies,
11.5.8.6. Financials (Based on Availability)
11.5.9. West Pharmaceutical Services, Inc.
11.5.9.1. Overview,
11.5.9.2. Product Type& Services,
11.5.9.3. SWOT Analysis,
11.5.9.4. Recent Developments,
11.5.9.5. Strategies,
11.5.9.6. Financials (Based on Availability)
11.5.10. Ypsomed AG
11.5.10.1. Overview,
11.5.10.2. Product Type& Services,
11.5.10.3. SWOT Analysis,
11.5.10.4. Recent Developments,
11.5.10.5. Strategies,
11.5.10.6. Financials (Based on Availability)
11.5.11. Gerresheimer AG
11.5.11.1. Overview,
11.5.11.2. Product Type& Services,
11.5.11.3. SWOT Analysis,
11.5.11.4. Recent Developments,
11.5.11.5. Strategies,
11.5.11.6. Financials (Based on Availability)
11.5.12. Baxter International Inc
11.5.12.1. Overview,
11.5.12.2. Product Type& Services,
11.5.12.3. SWOT Analysis,
11.5.12.4. Recent Developments,
11.5.12.5. Strategies,
11.5.12.6. Financials (Based on Availability)
11.5.13. Other Prominent Players
11.5.13.1. Overview,
11.5.13.2. Product Type& Services,
11.5.13.3. SWOT Analysis,
11.5.13.4. Recent Developments,
11.5.13.5. Strategies,
11.5.13.6. Financials (Based on Availability)
12. Strategic Recommendations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us